UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lysins: the arrival of pathogen-directed anti-infectives

Journal of medical microbiology, 2013-10, Vol.62 (10), p.1506-1516

2013

Volltextzugriff (PDF)

Biofilm formation by enterococci

Journal of medical microbiology, 2007-12, Vol.56 (12), p.1581-1588

2007

Volltextzugriff (PDF)

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

PloS one, 2022-09, Vol.17 (9), p.e0274815-e0274815

2022

Volltextzugriff (PDF)

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections

Diagnostics (Basel), 2019-04, Vol.9 (2), p.37

2019

Volltextzugriff (PDF)

Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe

Diagnostic microbiology and infectious disease, 2019-02, Vol.93 (2), p.154-158

2019

Volltextzugriff (PDF)

The activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study

Diagnostic microbiology and infectious disease, 2021-04, Vol.99 (4), p.115296-115296, Article 115296

Huang, David B

2021

Volltextzugriff (PDF)

A review of an emerging enteric pathogen: enteroaggregative Escherichia coli

Journal of medical microbiology, 2006-10, Vol.55 (10), p.1303-1311

2006

Volltextzugriff (PDF)

A pharmacokinetic and pharmacodynamic evaluation of iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse abscess model

Journal of medical microbiology, 2019-01, Vol.68 (1), p.77-80

Huang, David B

2019

Volltextzugriff (PDF)

K2 Serotype Klebsiella pneumoniae Causing a Liver Abscess Associated with Infective Endocarditis

Journal of Clinical Microbiology, 2010-02, Vol.48 (2), p.639-641

2010

Volltextzugriff (PDF)

Extracellular and intracellular activity of iclaprim against Listeria monocytogenes

International journal of antimicrobial agents, 2019-01, Vol.53 (1), p.106-107

Huang, David B.

2019

Volltextzugriff (PDF)

Enteroaggregative Escherichia coli Is a Cause of Acute Diarrheal Illness: A Meta-Analysis

Clinical infectious diseases, 2006-09, Vol.43 (5), p.556-563

2006

Volltextzugriff (PDF)

In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study

The Canadian journal of infectious diseases & medical microbiology, 2017-01, Vol.2017 (2017), p.1-6

2017

Volltextzugriff (PDF)

A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

Infectious diseases and therapy, 2020-03, Vol.9 (1), p.89-106

2020

Volltextzugriff (PDF)

Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017

Diagnostic microbiology and infectious disease, 2020-05, Vol.97 (1), p.115013-115013, Article 115013

2020

Volltextzugriff (PDF)

In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018

Journal of global antimicrobial resistance., 2021-06, Vol.25, p.14-17

2021

Volltextzugriff (PDF)

Association of Putative Enteroaggregative Escherichia coli Virulence Genes and Biofilm Production in Isolates from Travelers to Developing Countries

Journal of Clinical Microbiology, 2007-01, Vol.45 (1), p.121-126

2007

Volltextzugriff (PDF)

Impact of Weight on Treatment Efficacy and Safety in Complicated Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus

Clinical therapeutics, 2013-10, Vol.35 (10), p.1557-1570

2013

Volltextzugriff (PDF)

Iclaprim, a dihydrofolate reductase inhibitor antibiotic in Phase III of clinical development: a review of its pharmacology, microbiology and clinical efficacy and safety

Future microbiology, 2018-07, Vol.13 (9), p.957-969

2018

Volltextzugriff (PDF)

A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult Subjects

Antimicrobial agents and chemotherapy, 2022-03, Vol.66 (3), p.e0184221-e0184221

2022

Volltextzugriff (PDF)

In Vitro Activity of Iclaprim against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure Infections

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia

The Journal of infectious diseases, 2014-05, Vol.209 (9), p.1469-1478

2014

Volltextzugriff (PDF)

In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens

Antimicrobial agents and chemotherapy, 2019-12, Vol.64 (1)

2019

Volltextzugriff (PDF)

A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies

Clinical therapeutics, 2019-06, Vol.41 (6), p.1090-1096

2019

Volltextzugriff (PDF)

Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002 to 2019

Diagnostic microbiology and infectious disease, 2021-11, Vol.101 (3), p.115471-115471, Article 115471

2021

Volltextzugriff (PDF)

1 – 25 von 4.002

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.682)
Mit Volltextzugriff
(3.413)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.930)
Life Sciences & Biomedicine
(2.150)
Humans
(1.640)
Male
(814)
Female
(801)
Animals
(603)
Physical Sciences
(516)
Biological And Medical Sciences
(492)
Middle Aged
(477)
Adult
(455)
Aged
(371)
Medical Sciences
(364)
Technology
(294)
Mice
(286)
Science & Technology - Other Topics
(283)
Oncology
(272)
Biochemistry & Molecular Biology
(249)
Multidisciplinary Sciences
(238)
Cell Biology
(202)
Chemistry
(197)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.066)
EZB Electronic Journals Library
(2.016)
Ingenta
(1.500)
Lippincott Journal Package
(1.273)
Publisher website
(1.130)
Elsevier ScienceDirect Journals Complete
(742)
IngentaConnect Journals
(466)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(459)
Wiley Online Library All Journals
(362)
Nature Journals
(341)
SpringerLink
(263)
Wiley Online Library Full Collection 2018
(241)
Nexis Uni
(215)
JSTOR
(164)
Oxford Journals Online Current
(162)
Oxford Journals 2020 Medicine
(130)
IEEE Electronic Library Online
(125)
Ebook Central Perpetual and DDA
(123)
eBooks on EBSCOhost
(117)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(111)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lysins: the arrival of pathogen-directed anti-infectives

Biofilm formation by enterococci

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections

Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe

The activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study

A review of an emerging enteric pathogen: enteroaggregative Escherichia coli

A pharmacokinetic and pharmacodynamic evaluation of iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse abscess model

K2 Serotype Klebsiella pneumoniae Causing a Liver Abscess Associated with Infective Endocarditis

Extracellular and intracellular activity of iclaprim against Listeria monocytogenes

Enteroaggregative Escherichia coli Is a Cause of Acute Diarrheal Illness: A Meta-Analysis

In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study

A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017

In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018

Association of Putative Enteroaggregative Escherichia coli Virulence Genes and Biofilm Production in Isolates from Travelers to Developing Countries

Impact of Weight on Treatment Efficacy and Safety in Complicated Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus

Iclaprim, a dihydrofolate reductase inhibitor antibiotic in Phase III of clinical development: a review of its pharmacology, microbiology and clinical efficacy and safety

A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult Subjects

In Vitro Activity of Iclaprim against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure Infections

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia

In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens

A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies

Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim

Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002 to 2019

Suchergebnisse filtern